Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2018) | Total Docs. (3years) | Total Refs. (2018) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2018) | %Female (2018) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Theranostics | journal | 2.176 Q1 | 158 | 425 | 655 | 25196 | 5581 | 640 | 8.17 | 59.28 | 38.61 |  |
| 2 | Nanotechnology, Science and Applications | journal | 1.755 Q1 | 35 | 3 | 25 | 213 | 290 | 25 | 8.53 | 71.00 | 40.00 |  |
| 3 | Infection and Drug Resistance | journal | 1.354 Q1 | 65 | 258 | 131 | 10627 | 532 | 128 | 3.15 | 41.19 | 43.17 | |
| 4 | International Journal of Nanomedicine | journal | 1.098 Q1 | 179 | 605 | 1696 | 30652 | 8610 | 1683 | 4.74 | 50.66 | 41.95 | |
| 5 | Diabetes, Metabolic Syndrome and Obesity | journal | 0.997 Q1 | 64 | 90 | 154 | 4065 | 547 | 152 | 3.45 | 45.17 | 41.03 | |
| 6 | Drug Design, Development and Therapy | journal | 0.986 Q1 | 94 | 378 | 1213 | 16732 | 4161 | 1188 | 3.23 | 44.26 | 40.46 | |
| 7 | Pharmacogenomics and Personalized Medicine | journal | 0.965 Q2 | 37 | 23 | 61 | 1180 | 199 | 58 | 3.22 | 51.30 | 50.45 | |
| 8 | Biomarker Insights | journal | 0.758 Q2 | 40 | 24 | 117 | 1491 | 247 | 116 | 1.98 | 62.13 | 46.34 | |
| 9 | Patient Preference and Adherence | journal | 0.757 Q1 | 67 | 264 | 645 | 10391 | 1472 | 632 | 2.23 | 39.36 | 50.48 | |
| 10 | Core Evidence (discontinued) | journal | 0.501 Q3 | 29 | 3 | 15 | 136 | 33 | 15 | 2.43 | 45.33 | 38.46 | |
| 11 | Drug, Healthcare and Patient Safety | journal | 0.343 Q3 | 30 | 11 | 41 | 602 | 64 | 41 | 1.71 | 54.73 | 45.10 | |
| 12 | Fluoride - Quarterly Reports | journal | 0.323 Q4 | 51 | 32 | 132 | 1198 | 142 | 119 | 0.98 | 37.44 | 40.46 | |
| 13 | Open Access Journal of Clinical Trials | journal | 0.143 Q3 | 15 | 5 | 20 | 221 | 16 | 20 | 0.64 | 44.20 | 45.83 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data